Purpose
to evaluate the effectiveness of COVID-19 vaccine for the prevention of symptomatic, reverse transcription-polymerase chain reaction (RT-PCR) confirmed SARS-CoV-2 infection among healthcare workers in Kenya
Grantee
Division
Global Development
Date
NOVEMBER 2021
Region served
AFRICA
Committed amount
$600,000
Grant topic
Research and Learning Opportunities
Duration (months)
25
Grantee location
Oxford, Oxfordshire, United Kingdom
More about our work
Our work
Learn about where we work around the globe and the programs we’ve created to address urgent issues in global health, global development, and education.
How we work
We are focused on results. Those that can be measured. And those measured in ways beyond numbers.